Liposome

Cis-AY 9944 is a cholesterol synthesis inhibitor that specifically targets liposomal pathways. It demonstrates anticonvulsant activity by modulating the dynamics of spike-and-wave discharges observed in electroencephalogram (EEG) recordings. This compound is valuable for research into epilepsy mechanisms and metabolic processes involving cholesterol regulation.